Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × fludarabine × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 85 Precursor Cell Lymphoblastic Leukemia-Lymphoma 54 Myelodysplastic Syndromes 47 Lymphoma, Non-Hodgkin 38 Lymphoma 34 Multiple Myeloma 33 Leukemia, Lymphocytic, Chronic, B-Cell 32 Lymphoma, B-Cell 29 Recurrence 27 Lymphoma, Large B-Cell, Diffuse 27 Hematologic Neoplasms 25 Lymphoma, Follicular 24 Lymphoma, Mantle-Cell 22 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20 Lymphoma, B-Cell, Marginal Zone 19 Leukemia 19 Myeloproliferative Disorders 18 Melanoma 18 Leukemia, Biphenotypic, Acute 18 Hodgkin Disease 18 Pancreatic Neoplasms 15 Burkitt Lymphoma 15 Ovarian Neoplasms 14 Neoplasms 14 Leukemia, Myelomonocytic, Chronic 12 Anemia, Refractory, with Excess of Blasts 11 Colorectal Neoplasms 9 Stomach Neoplasms 7 Primary Myelofibrosis 7 Osteosarcoma 7

Interventions

Carboplatin 4 pembrolizumab 3 Paclitaxel 3 Capecitabine 3 Azacitidine 3 venetoclax 2 pertuzumab 2 olaparib 2 durvalumab 2 Trastuzumab 2 Standard of Care 2 Oxaliplatin 2 Observation 2 Irinotecan 2 Immunotherapy 2 Immune Checkpoint Inhibitors 2 Chemoradiotherapy 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 taxane 1 talazoparib 1 tagraxofusp 1 sarilumab 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡